SERPINA1 and hemophilia A: In genetic lung diseases, such as alpha-1 antitrypsin (A1AT) deficiency and pulmonary arterial hypertension, and in systemic diseases like hemophilia A and B, lifelong expression of a corrective gene is a prerequisite for the success of gene therapy.